ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,062Medicare Part D Prescriptions Filled, Including Refills

Rank: 133 out of 1024

$505K Total Retail Price of All Prescriptions

Rank: 245 out of 1024

658 Patients Receiving at Least One Drug in Part D
97% Patients 65 Years and Older
17% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Connecticut
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

3% of this provider’s 658 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

N/A

Brand Name Drugs*

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $68 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
ATORVASTATIN CALCIUM 812 807* 132 1 1
SIMVASTATIN 621 616* 107 2 5
LEVOTHYROXINE SODIUM 564 559* 94 3 2
AMLODIPINE BESYLATE 383 383 70 4 3
LISINOPRIL 320 315* 50 5 4
WARFARIN SODIUM 303 281 36 6 8
SYNTHROID 269 269 37 7 43
METOPROLOL SUCCINATE 208 203* 36 8 12
ESCITALOPRAM OXALATE 192 187* 30 9 14
HYDROCHLOROTHIAZIDE 187 187 34 10 11
ZOLPIDEM TARTRATE 182 182 51 11 19
ALLOPURINOL 173 173 29 12 34
AZITHROMYCIN 172 167* 131 13 50
METFORMIN HCL 141 141 23 14 10
CRESTOR 138 133* 18 15 20
FUROSEMIDE 135 135 28 16 6
ATENOLOL 132 132 26 17 13
BENICAR HCT 124 119* 18 18 112
PRAVASTATIN SODIUM 123 118* 26 19 15
AZOR 118 118 16 20 196
LOSARTAN POTASSIUM 118 113* 23 20 16
AMLODIPINE BESYLATE-BENAZEPRIL 115 115 18 22 85
SERTRALINE HCL 114 109* 17 23 23
DIOVAN 107 102* 20 24 21
MONTELUKAST SODIUM 105 105 48 25 46
METOPROLOL TARTRATE 102 102 18 26 7
OMEPRAZOLE 101 101 20 27 9
AMOX TR-POTASSIUM CLAVULANATE 98 93* 84 28 111
TRIAMTERENE-HCTZ 97 92* 16 29 60
CARVEDILOL 89 84* 18 30 40
ALPRAZOLAM 86 86 30 B 31 17
DIGOX 85 85 13 32 81
CLOPIDOGREL 81 81 13 33 28
DONEPEZIL HCL 77 77 11 34 25
BENICAR 76 71* 16 35 83
PANTOPRAZOLE SODIUM 73 68* 12 36 29
ADVAIR DISKUS 69 64* 23 37 41
CLONAZEPAM 68 63* 22 B 38 57
NAMENDA 67 <11 <11 39 27
FLUTICASONE PROPIONATE 67 62* 39 39 51
CEFUROXIME 65 65 54 41 136
AMITRIPTYLINE HCL 60 55* 18 R 42 156
BENAZEPRIL HCL 59 59 11 43 126
CIPROFLOXACIN HCL 57 52* 49 44 78
NEXIUM 55 <11 <11 45 33
VALSARTAN-HYDROCHLOROTHIAZIDE 54 <11 <11 46 64
SPIRONOLACTONE 54 49* 12 46 71
DILTIAZEM 24HR ER 53 48* 12 48 108
ZETIA 52 47* 13 49 52
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 12, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.